Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 2025-10-10 12:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Ubiquity AS 2 Details of the person discharging managerial responsibilities a) Name Susanne Stuffers | – | acquisition | 1,85 | 1,815 NOK | 2025-10-10 | NO0010714785 | XOSL - Oslo Stock Exchange | rules · til gjennomgang |
Vedlegg
- 251010 Attachment Ubiquity.pdf (tekst hentet ut)
Meldingstekst
Ubiquity AS has today acquired 280,000 shares in Nykode Therapeutics ASA at an average price of NOK 1.8113 per share. Susanne Stuffers, Chair of the Board and primary insider in Nykode Therapeutics ASA, is the owner of Ubiquity AS. Following the transaction Susanne Stuffers holds 280,000 shares in Nykode Therapeutics ASA through Ubiquity AS and 16,665 shares directly.
Please see further details in the attached document.